- Tracking Exercise by Steps or Minutes? Study Finds Either Method Boosts Health
- Stomach Paralysis Risk May Rise in People Taking Ozempic and Similar Drugs
- In a Shift, Pediatricians’ Group Says Breastfeeding Safe When HIV-Positive Mom Is Properly Treated
- Fertility Treatments Safe for Breast Cancer Survivors With Cancer-Linked Genes
- 1 in 4 Parents Say Their Teen Drinks Caffeine Daily
- New Blood Test Could Spot Dangerous Type of Stroke
- Blood Pressure Meds Raise Fracture Risks for Those in Nursing Homes
- Could Infertility Treatment Raise Postpartum Heart Risks?
- Does It Matter What You Eat or Drink Before Bed?
- Your Allergy Meds Come With Hazards: Be Aware
Test to Differentiate HIV Viruses Approved
A new diagnostic to differentiate between strains of the AIDS-causing virus has been approved by the U.S. Food and Drug Administration.
The Bio-Rad BioPlex 2200 HIV Ag-Ab assay can distinguish between HIV-1 and HIV-2, the FDA said in a news release. The diagnostic is approved for people aged two years and older, including pregnant women.
The test can be used to screen organ donors for either strain of the HIV virus, but it’s not been approved to routinely screen donated blood or plasma for the virus, the agency said.
While cases of HIV-2 have been diagnosed in the United States, HIV-2 has been found primarily in West Africa, the FDA said. Most cases in the United States have been linked to HIV-1. The viruses are similar yet distinct.
The new diagnostic is produced by Bio-Rad Laboratories, based in Hercules, Calif.
More information
Visit the FDA to learn more.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.